Over deze podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 0.5% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
211 afleveringen · Geneeskunde
On The Pen GLP-1 News
Nieuwste afleveringEli Lilly vs. The Grey Market: The Future of Peptide Medicine
Over deze podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 0.5% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
Recente afleveringen
- Ozempic & Zepbound Are Changing America in Ways Nobody Expected7 okt · 25 min
- They TRIPLED Wegovy Dose, Does it Beat Zepbound?1 okt · 31 min
- Retatrutide in Court, Compound GLP-1 Under Fire22 sep · 30 min
- 17% Weight Loss in 16 Weeks… Is This Better Than Retatrutide?15 sep · 30 min
- GLP-1 for 6 Year Olds? Here’s What the Trial Actually Found8 sep · 26 min
- We’re Solving Obesity. Now Who Pays for It?2 sep · 25 min
- GLP-1 Coverage Is COLLAPSING in 202726 aug · 35 min
- $50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”18 aug · 45 min
- 200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study12 aug · 31 min
- Eli Lilly Earnings Call Recap: Retatrutide News7 aug · 1 u 00 min
sharemy.show/on-the-pen-glp-1-news
Voor op een poster of slide.